APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Apyx Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.42−0.13 (-5.10%)
Close on Oct 19, 2026
- Market cap
- $106.12M
- P/E (TTM)
- –
- Dividend yield
- –
Apyx Medical Corp revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics [Member] | $12.39M | $10.73M | $16.71M | $11.07M | $9.67M | $7.89M | $12.10M | $9.29M | – | – | – | – | 89.2% | +28.1% |
| OEM [Member] | $1.50M | $1.76M | $2.45M | $1.81M | $1.70M | $1.54M | $2.12M | $2.20M | $2.38M | $2.79M | $2.53M | $2.14M | 10.8% | -12.0% |
| OEM | – | – | – | – | – | – | – | – | $2.38M | $2.79M | $2.53M | $2.14M | – | – |
| Advanced Energy [Member] | – | – | – | – | $9.67M | $7.89M | $12.10M | $9.29M | $9.77M | $7.45M | $12.13M | $9.84M | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics [Member] | $1.86M | $1.99M | $4.11M | $1.90M | $662.00K | $15.00K | $1.22M | -$469.00K | – | – | – | – | +181.3% |
| OEM [Member] | $214.00K | $443.00K | $915.00K | $667.00K | $181.00K | $92.00K | $407.00K | $373.00K | $461.00K | $732.00K | $729.00K | $591.00K | +18.2% |
| OEM | – | – | – | – | – | – | – | – | $461.00K | $732.00K | $729.00K | $591.00K | – |
| Advanced Energy [Member] | – | – | – | – | $662.00K | $15.00K | $1.22M | -$469.00K | -$1.70M | -$2.94M | -$6.00K | -$63.00K | – |
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $9.41M | $8.11M | $14.95M | $9.33M | $7.78M | $6.74M | $10.56M | $7.79M | $8.69M | $6.98M | $10.69M | $8.65M | 67.8% | +21.0% |
| Non-US [Member] | $4.48M | $4.38M | $4.21M | $3.55M | $3.60M | $2.69M | $3.66M | $3.69M | $3.46M | $3.27M | $3.98M | $3.32M | 32.2% | +24.4% |
From the segment and revenue-disaggregation notes of Apyx Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.